Decreased Quantitative Cerebral Blood Volume Is Associated With Poor Outcomes in Large Core Patients.

Background: Recent large core trials have highlighted the effectiveness of mechanical thrombectomy (MT) in acute ischemic stroke with large vessel occlusion. Variable perfusion-imaging thresholds and poor Alberta Stroke Program Early Computed Tomography Score reliability underline the need for more standardized, quantitative ischemia measures for MT patient selection. We aimed to identify the computed tomography perfusion parameter most strongly associated with poor outcomes in patients with acute ischemic stroke-large vessel occlusion with significant ischemic cores.
Methods: In this study from 2 comprehensive stroke centers from 2 comprehensive stroke centers within the Johns Hopkins Medical Enterprise (Johns Hopkins Hospita-East Baltimore and Bayview Medical Campus) from July 29, 2019 to January 29, 2023 in a continuously maintained database, we included patients with acute ischemic stroke-large vessel occlusion with ischemic core volumes defined as relative cerebral blood flow <30% and ≥50 mL on computed tomography perfusion or Alberta Stroke Program Early Computed Tomography Score <6. We used receiver operating characteristics to find the optimal cutoff for parameters like cerebral blood volume (CBV) <34%, 38%, 42%, and relative cerebral blood flow >20%, 30%, 34%, 38%, and time-to-maximum >4, 6, 8, and 10 seconds. The primary outcome was unfavorable outcomes (90-day modified Rankin Scale score 4-6). Multivariable models were adjusted for age, sex, diabetes, baseline National Institutes of Health Stroke Scale, intravenous thrombolysis, and MT.
Results: We identified 59 patients with large ischemic cores. A receiver operating characteristic curve analysis showed that CBV<42% ≥68 mL is associated with unfavorable outcomes (90-day modified Rankin Scale score 4-6) with an area under the curve of 0.90 (95% CI, 0.82-0.99) in the total and MT-only cohorts. Dichotomizing at this CBV threshold, patients in the ≥68 mL group exhibited significantly higher relative cerebral blood flow, time-to-maximum >8 and 10 seconds volumes, higher CBV volumes, higher HIR, and lower CBV index. The multivariable model incorporating CBV<42% ≥68 mL predicted poor outcomes robustly in both cohorts (area under the curve for MT-only subgroup was 0.87 [95% CI, 0.75-1.00]).
Conclusions: CBV<42% ≥68 mL most effectively forecasts poor outcomes in patients with large-core stroke, confirming its value alongside other parameters like time-to-maximum in managing acute ischemic stroke-large vessel occlusion.
Competing Interests: Dr Yedavalli reports compensation from IschemaView (RAPID AI) for consultant services and compensation from MRIOnline for consultant services. Dr Guenego reports compensation from Acandis for consultant services; compensation from Rapid Medical Ltd for consultant services; and compensation from phenox, Inc, for consultant services. Dr Heit reports compensation from iSchemaView for consultant services; compensation from Medtronic for consultant services; and compensation from MicroVention Inc for consultant services. Dr Albers reports compensation from iSchemaView for consultant services; compensation from Genentech for consultant services; and stock holdings in iSchemaView. Dr Urrutia reports grants from Genentech and employment by Johns Hopkins University School of Medicine. Dr Nael reports compensation from BRAINOMIX LIMITED for consultant services and compensation from Olea Medical for consultant services. Dr Hillis reports compensation from American Heart Association for other services; compensation from Elsevier Publishing for other services; employment by Johns Hopkins University School of Medicine; compensation from National Institute on Deafness and Other Communication Disorders for other services; and grants from National Institute on Deafness and Other Communication Disorders. The other authors report no conflicts.